The effect of human recombinant epidermal growth factor in the treatment of diabetic foot ulcers
Objectives. Diabetic foot ulcer (DFU) is one of the most important and common complication of type 2 diabetes mellitus (T2DM). A new therapy, consisting of intralesional administration of human recombinant epidermal growth factor (hrEGF), has been suggested to accelerate wound healing and prevent am...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Digital ProScholar Media
2022-05-01
|
| Series: | Journal of Clinical and Investigative Surgery |
| Subjects: | |
| Online Access: | https://www.e-repository.org/jcis/7/1/7.pdf |